PDS Biotechnology Corporation
PDSB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | – | – | – | – |
| R&D Expenses | $5 | $4 | $6 | $5 |
| G&A Expenses | $0 | $3 | $3 | $0 |
| SG&A Expenses | $4 | $3 | $3 | $3 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $8 | $8 | $9 | $7 |
| Operating Income | -$8 | -$8 | -$9 | -$7 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$1 | -$2 | -$1 | -$1 |
| Pre-Tax Income | -$9 | -$9 | -$10 | -$8 |
| Tax Expense | $0 | $0 | -$1 | $0 |
| Net Income | -$9 | -$9 | -$8 | -$8 |
| % Margin | – | – | – | – |
| EPS | -0.19 | -0.21 | -0.21 | -0.22 |
| % Growth | 9.5% | 0% | 4.5% | – |
| EPS Diluted | -0.19 | -0.21 | -0.21 | -0.22 |
| Weighted Avg Shares Out | 47 | 46 | 41 | 36 |
| Weighted Avg Shares Out Dil | 47 | 46 | 41 | 36 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $1 |
| Interest Expense | $1 | $2 | $1 | $1 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$8 | -$7 | -$9 | -$7 |
| % Margin | – | – | – | – |